KJIM :: Korean Journal of Internal Medicine

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer

Donghan Xu, Yehao Luo, Peng Wang, Jiaxin Li, Linrui Ma, Jie Huang, Hao Zhang, Xiaoman Yang, Liqi Li, Yuhong Zheng, Gang Fang, Peiyu Yan

Identification of Immuno-Inflammation-Related Biomarkers for Acute Myocardial Infarction Based on Bioinformatics

Journal of Inflammation Research.2023; Volume 16: 3283. CrossRef

Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?

R. Sacco, J. Woolley, G. Patel, M.D. Calasans-Maia, J. Yates

British Journal of Oral and Maxillofacial Surgery.2022; 60(2): e216. CrossRef

Ramucirumab-related osteonecrosis of the jaw

Annu Singh, Andrew Pischek, Joseph R. Randazzo, Joseph M. Huryn, Cherry L. Estilo, Isabel Preeshagul, SaeHee K. Yom

Anti-angiogenic potential of novel 31kDa protein of Zanthoxylum rhesta is mediated by inhibition of HIF-1α nuclear translocation in vivo

Priyanka Dattaraj Naik Parrikar, K.S. Balaji, K.K. Dharmappa, A.D. Sathisha, Shankar Jayarama

Advances in Cancer Biology - Metastasis.2022; 5: 100063. CrossRef

A homogalacturonan from Lonicera japonica Thunb. disrupts angiogenesis via epidermal growth factor receptor and Delta-like 4 associated signaling

Wenfeng Liao, Xiaodong Hu, Zhenyun Du, Peipei Wang, Kan Ding

Glycoconjugate Journal.2022; 39(6): 725. CrossRef

Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)

Diana Florina Nica, Mircea Riviș, Ciprian Ioan Roi, Carmen Darinca Todea, Virgil-Florin Duma, Cosmin Sinescu

Prolyl 3-Hydroxylase 2 Is a Molecular Player of Angiogenesis

Paola Pignata, Ivana Apicella, Valeria Cicatiello, Caterina Puglisi, Sara Magliacane Trotta, Remo Sanges, Valeria Tarallo, Sandro De Falco

International Journal of Molecular Sciences.2021; 22(8): 3896. CrossRef

Anti-Angiogenic Property of Free Human Oligosaccharides

Boram Bae, Haeun Kim, Hyerin Park, Young Jun Koh, Sung-Jin Bae, Ki-Tae Ha

The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids

Sarah Line Bring Truelsen, Nabi Mousavi, Haoche Wei, Lucy Harvey, Rikke Stausholm, Erik Spillum, Grith Hagel, Klaus Qvortrup, Ole Thastrup, Henrik Harling, Harry Mellor, Jacob Thastrup, Christina L. Addison

Progranulin deficiency in Iba-1+ myeloid cells exacerbates choroidal neovascularization by perturbation of lysosomal function and abnormal inflammation

Kei Takahashi, Shinsuke Nakamura, Wataru Otsu, Masamitsu Shimazawa, Hideaki Hara

Journal of Neuroinflammation.2021;[Epub] CrossRef

Different Presentation and Outcomes in the Surgical Treatment of Advanced MRONJ in Oncological and Nononcological Patients Taking or Not Corticosteroid Therapy

Paolo Garzino Demo, Alessandro Bojino, Fabio Roccia, Maria Chiara Malandrino, Stefan Cocis, Guglielmo Ramieri, Giulio Gasparini

BioMed Research International.2021; 2021: 1. CrossRef

Anti-inflammatory Effects of GTE in Eye Diseases

Jian Li, Lin Du, Jing Na He, Kai On Chu, Cosmos Liutao Guo, Mandy Oi Man Wong, Chi Pui Pang, Wai Kit Chu

Frontiers in Nutrition.2021;[Epub] CrossRef

Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Valeria Tarallo, Emanuela Iaccarino, Valeria Cicatiello, Riccardo Sanna, Menotti Ruvo, Sandro De Falco

International Journal of Molecular Sciences.2020; 21(2): 410. CrossRef

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)

Journal of Hematology & Oncology.2020;[Epub] CrossRef

SNX9 determines the surface levels of integrin β1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9

Kazufumi Tanigawa, Masashi Maekawa, Takeshi Kiyoi, Jun Nakayama, Riko Kitazawa, Sohei Kitazawa, Kentaro Semba, Tomohiko Taguchi, Satoshi Akita, Motohira Yoshida, Kei Ishimaru, Yuji Watanabe, Shigeki Higashiyama

Journal of Cellular Physiology.2019; 234(10): 17280. CrossRef

The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis

Xiaobo Li, Yong Li, Weijin Lu, Minfeng Chen, Wencai Ye, Dongmei Zhang

Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports

Z. Mihaylova, R. Ugrinov, E. Aleksiev, P. Stanimirov

Acta Medica Bulgarica.2019; 46(2): 51. CrossRef

Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor

Chengying Xie, Xiaozhe Wan, Haitian Quan, Mingyue Zheng, Li Fu, Yun Li, Liguang Lou

Cancer Science.2018; 109(4): 1207. CrossRef

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature

Kununya Pimolbutr, Stephen Porter, Stefano Fedele

BioMed Research International.2018; 2018: 1. CrossRef

Customizable biomaterials as tools for advanced anti-angiogenic drug discovery

The Role of PDGFs and PDGFRs in Colorectal Cancer

Roberta M. Manzat Saplacan, Loredana Balacescu, Claudia Gherman, Romeo I. Chira, Anca Craiu, Petru A. Mircea, Cosmin Lisencu, Ovidiu Balacescu

Mediators of Inflammation.2017; 2017: 1. CrossRef

A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling

Yongrui Liu, Yuan He, Feifei Yang, Xiaonan Cong, Jinhua Wang, Shihong Peng, Dan Gao, Weifang Wang, Liping Lan, Xuexiang Ying, Mingyao Liu, Yihua Chen, Zhengfang Yi

Science China Life Sciences.2017; 60(2): 202. CrossRef

Tumor Blood Vessels and Vasculogenic Mimicry – Current Knowledge and Searching for New Cellular/Molecular Targets of Anti-Angiogenic Therapy

Agnieszka Knopik-Skrocka, Patrycja Kręplewska, Donata Jarmołowska-Jurczyszyn

Advances in Cell Biology.2017; 5(1): 50. CrossRef

Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion

Eric H. Nguyen, William T. Daly, Ngoc Nhi T. Le, Mitra Farnoodian, David G. Belair, Michael P. Schwartz, Connie S. Lebakken, Gene E. Ananiev, Mohammad Ali Saghiri, Thomas B. Knudsen, Nader Sheibani, William L. Murphy

Nature Biomedical Engineering.2017;[Epub] CrossRef

A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy

Deok-Hoon Kong, Mi Kim, Ji Jang, Hee-Jun Na, Sukmook Lee

International Journal of Molecular Sciences.2017; 18(8): 1786. CrossRef

Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy

Ana Cavaco, Maryam Rezaei, Stephan Niland, Johannes A. Eble

International Journal of Molecular Sciences.2017; 18(11): 2355. CrossRef

Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers

Roghaye Arezumand, Abbas Alibakhshi, Javad Ranjbari, Ali Ramazani, Serge Muyldermans

Frontiers in Immunology.2017;[Epub] CrossRef

Inflammation and its role in age-related macular degeneration

Anu Kauppinen, Jussi J. Paterno, Janusz Blasiak, Antero Salminen, Kai Kaarniranta

Cellular and Molecular Life Sciences.2016; 73(9): 1765. CrossRef

Identification of peptides derived from the C‐terminal domain of fibulin‐7 active for endothelial cell adhesion and tube formation disruption

Susana de Vega, Kentaro Hozumi, Nobuharu Suzuki, Risa Nonaka, Eimi Seo, Anna Takeda, Tomoko Ikeuchi, Motoyoshi Nomizu, Yoshihiko Yamada, Eri Arikawa‐Hirasawa

Peptide Science.2016; 106(2): 184. CrossRef

KSHV-Mediated Angiogenesis in Tumor Progression

Pravinkumar Purushothaman, Timsy Uppal, Roni Sarkar, Subhash Verma

Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells

C.C. Drewes, R.Y. Dias, V.G. Branco, M.F. Cavalcante, J.G. Souza, D.S.P. Abdalla, A.M. Chudzinski-Tavassi, S.H.P. Farsky

The vascular endothelial growth factors and receptors family: Up to now the only target for anti-angiogenesis therapy

The International Journal of Biochemistry & Cell Biology.2015; 64: 185. CrossRef

Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content

Teresia Kling, Patrik Johansson, José Sanchez, Voichita D. Marinescu, Rebecka Jörnsten, Sven Nelander

Nucleic Acids Research.2015; 43(15): e98. CrossRef

Prospects for early investigational therapies for sickle cell disease

Expert Opinion on Investigational Drugs.2015; 24(5): 595. CrossRef

Galectins in angiogenesis: consequences for gestation

Sandra M. Blois, Melanie L. Conrad, Nancy Freitag, Gabriela Barrientos

Journal of Reproductive Immunology.2015; 108: 33. CrossRef

Computational systems biology approaches to anti-angiogenic cancer therapeutics

Stacey D. Finley, Liang-Hui Chu, Aleksander S. Popel

Drug Discovery Today.2015; 20(2): 187. CrossRef

Antiangiogenic Effect of Ethanol Extract ofVigna angularisvia Inhibition of Phosphorylation of VEGFR2, Erk, and Akt

Oh Sung Kwon, Myoung Seok Jeong, Bonglee Kim, Sung-Hoon Kim

Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1. CrossRef

Advances and perspectives of colorectal cancer stem cell vaccine

Biomedicine & Pharmacotherapy.2015; 76: 107. CrossRef

Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice

YING LIU, XIZHENG XIA, MINGKAI ZHOU, XIAOJUN LIU

Experimental and Therapeutic Medicine.2015; 9(6): 2180. CrossRef

Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models

Valeria Cicatiello, Ivana Apicella, Laura Tudisco, Valeria Tarallo, Luigi Formisano, Annamaria Sandomenico, Younghee Kim, Ana Bastos-Carvalho, Augusto Orlandi, Jayakrishna Ambati, Menotti Ruvo, Roberto Bianco, Sandro De Falco

Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA

Comparative insight into expression of recombinant human VEGF111b, a newly identified anti-angiogenic isoform, in eukaryotic cell lines

Expert Opinion on Therapeutic Targets.2014; 18(11): 1339. CrossRef